Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology

Male Practice guidelines as topic Time Factors Calcineurin Inhibitors Comorbidity Dermatology Severity of Illness Index 03 medical and health sciences 0302 clinical medicine Adrenal Cortex Hormones Humans Psoriasis Biological therapy Vitamin D Societies, Medical Antibodies, Monoclonal Anthralin Phototherapy 3. Good health Drug Combinations Methotrexate RL1-803 Cyclosporine Female Dermatologic Agents Brazil
DOI: 10.1590/abd1806-4841.2019940211 Publication Date: 2019-06-01T19:49:52Z
ABSTRACT
Psoriasis is a chronic inflammatory disease that affects 1.3% of the Brazilian population. The most common clinical manifestations are erythematous, scaling lesions that affect both genders and can occur on any anatomical site, preferentially involving the knees, elbows, scalp and genitals. Besides the impact on the quality of life, the systemic nature of the disease makes psoriasis an independent risk factor for cardiovascular disease, especially in young patients with severe disease. By an initiative of the Brazilian Society of Dermatology, dermatologists with renowned clinical experience in the management of psoriasis were invited to form a work group that, in a partnership with the Brazilian Medical Association, dedicated themselves to create the Plaque Psoriasis Diagnostic and Treatment Guidelines. The relevant issues for the diagnosis (evaluation of severity and comorbidities) and treatment of plaque psoriasis were defined. The issues generated a search strategy in the Medline-PubMed database up to July 2018. Subsequently, the answers to the questions of the recommendations were devised, and each reference selected presented the respective level of recommendation and strength of scientific evidence. The final recommendations for making up the final text were worded by the coordinators.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (269)
CITATIONS (27)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....